Glaxosmithkline Pharmaceuticals Posts 34.7% Surge in Q4 Net Profit

The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025.

India May Face Drug Price Hikes after Trump Policy Shift

U.S. President Donald Trump’s latest administrative order pointing to cut domestic drug prices could wave across global pharmaceutical markets, with certain pressure on India to raise prices.

Indian Pharma Giants Brace for Impact Amid U.S. Drug Price Shake-Up

India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...

DCA Raids in Telangana Uncover Banned, Expired Drugs in Hospitals

During a massive crackdown across Telangana, Drug Control Administration (DCA) officials raided 66 pharmacies linked to corporate hospitals; they found a mass violation of regulations including sale of...

Zydus Gets USFDA Approval for Glatiramer Acetate, Copaxone Generic

Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL...

NPPA Caps Prices of 84 Drug Combinations, Including Empagliflozin Variants

The National Pharmaceutical Pricing Authority (NPPA) has set 84 drug formulations' retail prices, including 36 formulations of empagliflozin, a diabetes drug that was originally developed by German firm Boehringer Ingelheim...

FDCA Gujarat Acts Against Illegal Psychotropic Drug Sales

A significant attempt to stop illegal sale of narcotic and psychotropic drugs has been made by the Gujarat Food and Drugs Control Administration (FDCA) in a major crackdown effort on the illicit sale of drugs in the state...

Indian Drugmakers Face Heat as FDA Expands Surprise Global Inspections

In an effort to improve consumer safety and reinforce regulatory compliance, the US Food and Drug Administration (FDA) announced on Tuesday that it will raise the frequency of surprise inspections at foreign manufacturing facilities.

DTAB Recommends All Antimicrobials Be Treated as New Drugs to Tackle AMR

In a major regulatory move aimed at curbing antimicrobial resistance (AMR), the Drugs Technical Advisory Board (DTAB) has recommended that all antimicrobials should be permanently classified as...

Alembic Pharma Eyes FY26 Growth with Domestic Surge and Global Push

Alembic Pharmaceuticals has raised its expectation margin for FY26, with increased domestic sales, and international expansion. The CFO of the company, R.K.Baheti informed Moneycontrol that the company recorded higher E...